0 CHECKOUT

PRODUCT FILTERS

REGION

962
546
546
499
499

COUNTRY

489
64
48
39
39

CATEGORIES

  • 188

PRICE

113
367
829
2,313

PUBLISHED

249
368
959
2,313

PRODUCT TYPE

1,833
331
91
36
19
3

Central Nervous System Drugs Market Research Reports

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

Epilepsy: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis

Refractory patients, niche indication expansions, and geographical reach offer room for growth in an otherwise crowded epilepsy market. This report addresses the following questions: - Why do...

Published:  June 2016
Price:  From

Alzheimer's Disease: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis

Amyloid-targeting immunotherapies may create a $10bn opportunity within the Alzheimer’s disease market. This report addresses the following questions: - How will the approval of immunotherapies...

Published:  March 2016
Price:  From

Multiple Sclerosis: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis

Competition is mounting in the lucrative multiple sclerosis market, as new entrants and late-stage pipeline candidates look to capture market share from established players. This report addresses...

Published:  January 2016
Price:  From

Global Sleeping Aids Market Size, Share, Development, Growth and Demand Forecast to 2020 - Industry Insights by Sleep Disorders, Product, by Medication

The global sleeping aids market accounted for $61,798.0 million in 2015, and it is expected to grow at a CAGR of 6.3% during 2016-2022. The Insomnia sleep disorder segment dominated the global sleeping...

Published:  October 2015
Price:  From

Vitamin B6 (Pyridoxine) Market Analysis: By Drug Type (Tablet, Capsule, Syrup, Cream, and Others); By Use Cases - With Forecast (2016-2021)

Vitamin B6 (Pyridoxine) is a soluble vitamin type. Apart from pyridoxine vitamin B6 has two more natural forms such as pyridoxamine, and pyridoxal, which are majorly found in food contents. Pyridoxine...

Published:  March 2016
Price:  From

Neurotech Industry 2015-2016 Report: Drugs, Biologics, Stem Cells, Devices and Diagnostics for the Brain and Nervous System

Now in its 11th year, The Neurotechnology Industry 2015-2016 Report is an expanded and updated 650 page report of brain and nervous system markets and treatments. It is the only publication to provide...

Published:  September 2015
Price:  From

Alzheimer's Drugs Market Analysis: By Phase (Phase-I, Phase-II, Phase-III and Others); By Drug Type (NMDA Receptor Antagonist, Acetylcholinesterase Inhibitor) and Geography - Forecast to 2021

Alzheimer’s disease is classified as a progressive neurological disease that affects the functioning of the brain, ultimately leading to neuron loss. It is a neurodegenerative disease of the brain which...

Published:  February 2016
Price:  From

Amyotrophic Lateral Sclerosis Market: By Drug Type (Riluzole, Nuedexta) By Treatment Type (Stem Cell Therapy, Chemotherapy) By Distribution Partners(Hospitals, Diagnostic centres, Clinics, Retail Pharmacies) & Geography-Forecast (2014-2021)

Amyotrophic lateral sclerosis (ALS) is a neurological disease and also termed as Lou Gehrig’s disease which results in a specific disorder that involves the death of neurons that control voluntary muscles....

Published:  January 2016
Price:  From

India Neuropsychiatry (Drugs and Devices) Market: Trends, Opportunities and Forecasts (2015-2020F)

'India Neuropsychiatry (Drugs and Devices) Market: Trends, Opportunities and Forecasts (2015-2020F) - (Segmentation By Value and Volume, By Region, Diagnosis and Treatment Devices, Value Chain, Key...

Published:  December 2015
Price:  From

Global Epilepsy Drugs Market 2016-2020

About the Epilepsy Drugs Market Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused...

Published:  July 2016
Price:  From

Global Alzheimer’s Drug Market: Trends, Opportunities and Forecasts (2015-2020) (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: <65 years, >65 years age; By Region; Global Dementia Market)

The Global Alzheimer’s Market is growing at a moderate rate over last five years on account of rising expenditure on health care especially neurological disorders among ageing population and escalating...

Published:  December 2015
Price:  From

Global Migraine Drugs Market 2016-2020

About Migraines A migraine is characterized by repeated attacks of a severe headache, nausea, vomiting, and extreme sensitivity to light and sound. Women are more prone to the disease compared to men...

Published:  May 2016
Price:  From

Global Alzheimer's Therapeutic Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2012 To 2022

Alzheimer’s therapeutics market was esteemed at USD 8,524.9 Mn in 2015, and is relied upon to achieve USD 14,856.3 Mn by 2022, growing at a CAGR of 8.02% from 2016 to 2022. Market Insights: Alzheimer’s...

Published:  May 2016
Price:  From

Global Duchenne Muscular Dystrophy Drugs Market 2015-2019

About Duchenne muscular dystrophy Duchenne muscular dystrophy is an X-linked disease, which generally affects the male population. It is characterized by progressive muscle degeneration and weakness....

Published:  August 2015
Price:  From

Neuroprotection - Drugs, Markets and Companies

This report describes the role of neuroprotection in acute disorders such as stroke and injuries of the nervous system as well as in chronic diseases such as neurodegenerative disorders because many...

Published:  August 2016
Price:  From

Alzheimer Disease - New Drugs, Markets and Companies

Alzheimer's disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future. Considerable...

Published:  August 2016
Price:  From

Epilepsy Drugs Market in Europe - Market Analysis 2015-2019

About epilepsy Epilepsy refers to a spectrum of brain disorders manifested by benign to severe, disabling, and life-threatening symptoms. It is caused by factors ranging from brain malformations and...

Published:  September 2015
Price:  From

Alzheimer's Disease Therapeutics and Diagnostics: Global Markets

The global market for AD therapeutics and diagnostics by region should reach over $6.2 billion by 2020 from $4.4 billion in 2015, at a compound annual growth rate (CAGR) of 7.1% from 2015 to 2020. This...

Published:  March 2016
Price:  From

Global Central Nervous System (CNS) Biomarkers Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022

A biomarker is a biological feature that are used to measure the biological state, presence of diseases or progress of effects of treatment. It helps in understanding various chronic diseases, its effects...

Published:  May 2016
Price:  From

Global Central Nervous System (CNS) Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022

A biomarker is biological feature that can be used to measure the presence or progress of disease or the effects of treatment. For example, prostate specific antigen (PSA) is a biomarker for cancer...

Published:  March 2016
Price:  From
Loading Indicator

Our Clients